missing translation for 'onlineSavingsMsg'
Learn More

ACE/CD143 Antibody (230214), mFluor Violet 500 SE, Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals FAB15131MFV500

Product Code. 18543026

  • 589.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

ACE/CD143 Monoclonal antibody specifically detects ACE/CD143 in Mouse samples. It is validated for Flow Cytometry, Immunoprecipitation, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ACE/CD143
Monoclonal
mFluor Violet 500 SE
50mM Sodium Borate
Rat
0.1 mL
Cancer, Cardiovascular Biology, CD Markers, Cell Biology, Endocrinology, Immunology, Signal Transduction, Stem Cells
1636
Store at 4C in the dark.
Flow Cytometry, Immunoprecipitation, CyTOF
230214
Flow Cytometry, Immunoprecipitation, CyTOF-ready
ACE1angiotensin converting enzyme, somatic isoform, angiotensin I converting enzyme (peptidyl-dipeptidase A) 1, carboxycathepsin, CD143, CD143 antigen, DCP, DCP1angiotensin-converting enzyme, dipeptidyl carboxypeptidase 1, Dipeptidyl carboxypeptidase I, EC 3.2.1.-, EC 3.4.15.1, Kininase II, MGC26566, MVCD3, peptidase P, testicular ECA
Mouse myeloma cell line NS0-derived recombinant mouse ACE/CD143, Leu35-Glu1264, Accession # P09470
RUO
Primary
Mouse
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.